PCA
RMD icon

Pallas Capital Advisors’s ResMed RMD Stock Holding History

Pallas Capital Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,195
Closed -$288K – 957
2025
Q4 		$288K Buy
1,195
+11
+0.9% +$2.81K 0.01% 693
2025
Q3 		$324K Buy
1,184
+10
+0.9% +$2.73K 0.01% 654
2025
Q2 		$303K Sell
1,174
-1,924
-62% -$459K 0.01% 648
2025
Q1 		$693K Buy
3,098
+330
+12% +$77K 0.03% 382
2024
Q4 		$633K Buy
2,768
+751
+37% +$181K 0.03% 319
2024
Q3 		$482K Buy
2,017
+724
+56% +$162K 0.02% 366
2024
Q2 		$264K Buy
+1,293
New +$262K 0.01% 434
2023
Q2 		– Sell
-1,180
Closed -$271K – 294
2023
Q1 		$271K Buy
1,180
+7
+0.6% +$1.52K 0.03% 229
2022
Q4 		$275K Sell
1,173
-90
-7% -$19.8K 0.03% 231
2022
Q3 		$264K Sell
1,263
-28
-2% -$6.37K 0.03% 216
2022
Q2 		$299K Hold
1,291
– – 0.04% 187
2022
Q1 		$302K Sell
1,291
-64
-5% -$15.5K 0.04% 200
2021
Q4 		$319K Sell
1,355
-15
-1% -$3.89K 0.04% 245
2021
Q3 		$367K Buy
1,370
+89
+7% +$24.3K 0.04% 276
2021
Q2 		$350K Buy
1,281
+85
+7% +$17.9K 0.05% 234
2021
Q1 		$231K Buy
+1,196
New +$240K 0.05% 167

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pallas Capital Advisors's RMD Position: Q1 2026 in Review

Pallas Capital Advisors sold out of ResMed (RMD) in Q1 2026, closing a stake of 1,195 shares — an estimated $288K sold.

Pallas Capital Advisors first reported a position in RMD in Q1 2021 and held it in 16 quarters. The position peaked at $693K in Q1 2025. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Pallas Capital Advisors reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • Pallas Capital Advisors sold 1,195 ResMed shares in Q1 2026, an estimated $288K.
  • Pallas Capital Advisors first reported a position in ResMed in Q1 2021 and held it in 16 quarters.
  • Pallas Capital Advisors's ResMed position peaked at $693K in Q1 2025.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.